Leadership Team

Johan Liwing has over 15 years’ experience from leading positions within the life sciences industry in Sweden as well as internationally. During his 13 years at Janssen (Johnson & Johnson), he held various positions in health economics, sales & marketing as well as observational research with increased responsibilities. In his last position at Janssen, as a Global Senior Director, he was responsible for developing the use of observational data. Johan Liwing has also worked for Roche as well as in other areas outside the life sciences industry, such as finance and engineering.

Hugo Petit has more than 18 years of experience from various CFO roles in both listed and unlisted growth companies, primarily in the Life Science area. Previous positions include CFO at MedCap AB and OxThera AB. Hugo has also worked for several years as management consultant at McKinsey & Company. He holds a Master in Organizational and Behavioral Science from the Netherlands Military Academy in Breda, Netherlands and an MBA in Executive Management from Uppsala University in Sweden.

Dr. Peter Hovstadius received his MD from Uppsala University in 1992, his specialist license in Clinical Pharmacology 2002 and his PhD in cancer drug development in 2005. During his career, he has held Medical Director positions at several global research-based pharmaceutical companies, including Roche, MSD and Novartis. He has a solid experience in drug development and oncology, being part of launching over 20 new medicines. Most recently he spent 8 years as Chief Scientific Officer at Novartis Nordics. Dr Hovstadius has a deep passion for precision medicine and bringing life-saving therapies to patients in need more quickly.

Dr. Maltais received her PhD. in immunobiology and tumor immunology from Karolinska Institutet in 2006. Since then, she has been leading R&D activities and strategies within several organizations and has also had roles within corporate and business development. Most recently, she comes from Chiesi Farmaceutici S.p.A., a global company that develops and markets therapeutic solutions within a number of different therapeutic areas. At Chiesi, she was Head of CMC, Biotech Research and Product Development, Global Rare Diseases.

Markus Thor is a business development executive with over 25 years of experience from the life science industry. In previous roles he was responsible for structuring, negotiating, and closing a range of global, strategic business agreements, including in- and out-licensing, acquisitions, and R&D collaborations. Previous positions include Vice President & Head of Business Development at Biovitrum AB, Chief Business Officer at Kancera AB and Senior Investment Advisor at Business Sweden. Thor received his MBA from Stockholm School of Economics and his MSc in Chemistry from the University of Umeå in Sweden and the University of Sussex, UK.

Camilla Kihlman Larsson has more than 25 years of experience within the life science industry. She has deep expertise in manufacturing, project management, GMP, risk assessment and quality control. In previous roles she has been responsible for finalization and upgrading of manufacturing facility, leading manufacturing activities for packing site, material storage and dispensations, rebuilding of QC lab and installation and validation of equipment, and risk assessments. Most recently, she comes from AFRY as senior project management and risk manager at different companies (Astra Zeneca, SHL- group, XNK Therapeutics). At Astra Zeneca she had several positions as production manager, projects manager and lab engineer.

Linda Brink has more than 20 years of experience in the pharma industry and the areas of process development, manufacturing, and quality assurance of biopharmaceuticals. She has significant experience in building quality management systems and commercial cell culture. Her previous positions include Director of QA internal Manufacturing at Sobi and several positions as senior QA within Sobi and AstraZeneca. Linda Brink holds a M. Sc. in Biotechnology from the Royal Institute of Technology, Stockholm.